Alpine Immune Sciences

Alpine Immune Sciences

Alpine Immune Sciences

Modern therapies targeting the immune synapse. Founded 2015.
Type
Other
Founded
2015
Raised
$187M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
Team Size
1–10
Employees
$91,000,000 Post-IPO equity
GeekWire

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

GeekWire

Alpine Immune Sciences stock rises after landing $60M from AbbVie for lupus drug

Xconomy

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

GeekWire

Alpine Immune Sciences raising $17M in advance of merger with Colorado pharmaceutical company

Health Funding Strategy
Xconomy , GeekWire

Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M

Health
$48,000,000 Venture capital (Series A)
FinSMEs

Alpine Immune Sciences Closes $48M Series A Financing Round

Funding Science